(Reuters) - Mylan got marketing approval from the U.S. Food and Drug Administration for Glipizide and Metformin Hydrochloride Tablets in 2.5 mg/250 mg, 2.5 mg/500 mg and 5 mg/500 mg strengths. The product will be shipped immediately, the company said in a statement.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment